Jefferies Financial Group upgraded shares of Aveanna Healthcare (NASDAQ:AVAH - Free Report) from a hold rating to a buy rating in a research note released on Monday morning, Marketbeat.com reports. They currently have $6.00 target price on the stock, down from their previous target price of $6.25.
Other research analysts have also recently issued research reports about the stock. Barclays initiated coverage on shares of Aveanna Healthcare in a research report on Wednesday, July 2nd. They set an "equal weight" rating and a $5.50 price target on the stock. Truist Financial decreased their target price on shares of Aveanna Healthcare from $6.00 to $5.00 and set a "hold" rating on the stock in a research report on Wednesday, July 16th. Wall Street Zen cut shares of Aveanna Healthcare from a "strong-buy" rating to a "buy" rating in a research report on Friday, June 27th. Finally, UBS Group upped their target price on shares of Aveanna Healthcare from $4.50 to $5.00 and gave the company a "sell" rating in a research report on Friday, May 9th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $5.25.
Get Our Latest Analysis on Aveanna Healthcare
Aveanna Healthcare Stock Performance
Shares of AVAH stock traded down $0.09 on Monday, hitting $4.00. 139,365 shares of the stock traded hands, compared to its average volume of 376,350. The firm's 50-day moving average price is $4.91 and its two-hundred day moving average price is $4.82. The stock has a market capitalization of $779.38 million, a PE ratio of 199.75 and a beta of 1.98. Aveanna Healthcare has a twelve month low of $2.61 and a twelve month high of $6.19.
Insider Buying and Selling
In other Aveanna Healthcare news, insider Patrick A. Cunningham sold 18,500 shares of the business's stock in a transaction dated Friday, June 13th. The shares were sold at an average price of $4.93, for a total transaction of $91,205.00. Following the sale, the insider directly owned 327,869 shares in the company, valued at $1,616,394.17. This represents a 5.34% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, major shareholder J.H. Whitney Equity Partners V sold 1,560,700 shares of the business's stock in a transaction dated Monday, May 19th. The stock was sold at an average price of $5.36, for a total transaction of $8,365,352.00. Following the sale, the insider owned 29,640,756 shares in the company, valued at $158,874,452.16. This trade represents a 5.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 7,115,345 shares of company stock valued at $37,838,057 over the last three months. Company insiders own 7.80% of the company's stock.
Institutional Trading of Aveanna Healthcare
Institutional investors and hedge funds have recently bought and sold shares of the business. Banque Transatlantique SA purchased a new stake in Aveanna Healthcare during the first quarter worth about $25,000. BNP Paribas Financial Markets acquired a new stake in Aveanna Healthcare in the fourth quarter valued at approximately $35,000. KLP Kapitalforvaltning AS acquired a new stake in Aveanna Healthcare in the fourth quarter valued at approximately $35,000. Tower Research Capital LLC TRC raised its holdings in Aveanna Healthcare by 662.2% in the fourth quarter. Tower Research Capital LLC TRC now owns 7,889 shares of the company's stock valued at $36,000 after acquiring an additional 6,854 shares in the last quarter. Finally, Jump Financial LLC acquired a new stake in Aveanna Healthcare in the first quarter valued at approximately $59,000. 87.96% of the stock is currently owned by hedge funds and other institutional investors.
Aveanna Healthcare Company Profile
(
Get Free Report)
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
Featured Stories
Before you consider Aveanna Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aveanna Healthcare wasn't on the list.
While Aveanna Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access